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Patients with aortic stenosis are susceptible to myocardial ischemia during hemodynamic stress, which may be caused by two mechanisms. First, vascular abnormalities inherent in myocardial hypertrophy may impair coronary vasodilation, limiting the ability to increase coronary blood flow to meet increased metabolic demands. Second, aortic stenosis itself may cause an imbalance between oxygen supply and demand during hemodynamic stress by decreasing aortic pressure (decreasing coronary perfusion or oxygen supply) and increasing left ventricular pressure (increasing oxygen demand). By decreasing aortic valve gradient without immediately altering ventricular hypertrophy, aortic balloon valvuloplasty offers the opportunity to distinguish these mechanisms. We hypothesized that aortic valvuloplasty would improve the balance between myocardial oxygen supply and demand, especially during isoproterenol infusion. Nine patients undergoing aortic balloon valvuloplasty were assessed at baseline and during isoproterenol infusion (5 2 p,g/min, mean+ SD) before and after valvuloplasty. Valvuloplasty increased myocardial oxygen supply. After from 4 ,135 511 to 3,021 492 mm Hg-sec/min (p = 0.0002). Valvuloplasty improved the balance between myocardial oxygen supply and demand, increasing baseline DPTI:SPTI, decreasing aortocoronary sinus oxygen content difference (0.51 0.15 to 0.68 0.14, p = 0.005 and 96 14 to 78±+15 ml 02/1, p = 0.002, respectively), and decreasing myocardial lactate production during isoproterenol infusion (mean lactate extraction fraction, -0.26+± 0.40 to 0.14+0.17; p=0.01). We conclude that aortic valvuloplasty improves the balance between myocardial oxygen supply and demand during hemodynamic stress induced by isoproterenol infusion. We speculate that the clinical improvement, which often occurs in these patients after valvuloplasty despite persistence of hemodynamically "critical" aortic stenosis, is in part attributable to immediate improvement in the myocardial oxygen supply: demand ratio. (Circulation 1988; 78:573-582) patients with aortic stenosis often demonstrate metabolic evidence of myocardial ischemia during hemodynamic stress.1'2 Ischemia in aortic stenosis may be caused by two mechanisms onary blood flow to meet the demand until coronary arteries become maximally dilated, when coronary blood flow (myocardial oxygen supply) is determined by coronary perfusion pressure. 15 This study was performed in nine patients who had critical aortic stenosis and were undergoing aortic balloon valvuloplasty. There were five men and four women, whose age was 73 ± 19 (mean ± SD) years. These patients were being treated with furosemide (n = 6), hydrochlorothiazide (n = 1), digoxin (n = 5), captopril (n = 2), nifedipine (n = 1), and nitrates (n = 4). By clinical necessity, all medications were continued up to the time of valvuloplasty. Minor epicardial coronary disease was present on angiography in three patients (30-40% stenoses of the middle left anterior descending coronary artery in two patients and a 30% stenosis of the middle left circumflex coronary artery in one patient). All patients gave written consent to the protocol, which was approved by the University of Virginia Human Investigation Committee.
Valvuloplasty Protocol
All patients had previously undergone routine right and left heart catheterization at our institution with room-temperature 5% dextrose solution injected at 60 ml/sec.2l122 In two patients, serial injections from 48 to 66 ml/sec demonstrated that coronary sinus blood flows thus determined were independent of injection rate.
Baseline measurements were made including pulmonary artery, central aortic, and left ventricular pressures, thermodilution cardiac output and coronary sinus blood flow, and coronary sinus and ascending aortic lactate and oxygen saturations. Central aortic and left ventricular pressures were recorded simultaneously with thoroughly flushed disposable air reference transducers (Spectramed. Oxnard, California). Recording was repeated after switching and reflushing transducers. If peak-topeak gradients disagreed by more than 5 mm Hg, transducers were rebalanced against a mercury manometer and measurements were repeated. To induce hemodynamic stress, isoproterenol was infused in graded doses from 2 to 8 (mean, 5+2) gg/min, increasing the dose by 1-2 ,ug/min every 3-continued after dilation with the maximal balloon size deemed appropriate in each patient, which was determined by comparing fluoroscopic balloon profile with aortic valve calcium and observing for cessation of balloon motion or severe hypotension during balloon inflation. After valvuloplasty, 30 Diastolic and systolic pressure time indexes were planimetered from pressure tracings, converted to appropriate units, and multiplied by heart rate (mm Hg-sec/min, Figure 1 ). 10, 13 The ratio of DPTI: SPTI was then calculated. To Table 2 . Isoproterenol decreased DPTI more before than after valvuloplasty (p = 0.02). Isoproterenol increased coronary blood flow more after valvuloplasty, increasing coronary sinus blood flow in four of the seven patients in whom it was measured before valvuloplasty but in all seven patients after valvuloplasty (p =0.001, Figure 2) . Thus, valvuloplasty increased myocardial oxygen supply during the hemodynamic stress induced by isoproterenol infusion.
Oxygen Demand
Indexes of myocardial oxygen demand are also shown in Table 2 . Valvuloplasty significantly Figure 3) . Thus, valvuloplasty improved the balance between myocardial oxygen supply and demand.
Determinants of Coronary Flow and Calculated Vasodilator Reserve
The effect of valvuloplasty on coronary flow was studied further by examining the determinants of coronary flow (Table 3 in coronary blood flow to meet increased myocardial metabolic demands. Because regression of left ventricular hypertrophy would not occur for several weeks after valvuloplasty, this study does not assess this mechanism as a cause of ischemia in aortic stenosis. 19, 20 A second mechanism for myocardial ischemia is that aortic stenosis itself may cause an imbalance between myocardial oxygen supply and myocardial oxygen demand. An aortic valve gradient reduces the aortic pressure driving coronary perfusion pressure in relation to left ventricular pressure. In patients with aortic stenosis the ratio DPTI: SPTI, an index of the myocardial supply: demand ratio, decreases during myocardial lactate production induced by rapid ventricular pacing or isoproterenol infusion.9-13 Despite this evidence, the importance of an imbalance between myocardial oxygen supply and demand causing myocardial ischemia remains controversial. Some believe this mechanism insufficient to produce "major abnormalities of left ventricular perfusion" under "clinically relevant conditions."5 Others consider changes in load to be "4potentially important 
Clinical Importance
The susceptibility to myocardial ischemia demonstrated in this study in patients undergoing aortic valvuloplasty provides an explanation for immediate clinical improvement after valvuloplasty. Many patients claim dramatic relief of dyspnea and chest discomfort immediately after valvuloplasty despite minimal improvement in aortic valve area, which we have often attributed to placebo effect. Because isoproterenol infusion in part mimics the hemodynamic effects of exercise, the reduction in ischemia during isoproterenol infusion after valvuloplasty may explain the immediate reduction in symptoms. 38 Susceptibility to myocardial ischemia in these patients while undergoing the valvuloplasty procedure is also an important consideration. First, transvalvular balloon inflation increases aortic outflow obstruction, decreasing aortic pressure and increasing left ventricular pressure. In certain patients, the decline in arterial pressure during balloon inflation may start a downward spiral of progressive ischemia and left ventricular dysfunction, often resulting in death. We have reversed this spiral by prompt initiation of intra-aortic balloon pumping, which augments coronary perfusion pressure and reduces left ventricular load, thereby providing a specific antidote to this physiological derangement. 39 
